Digest Network Come funziona
Digest / Comunicato

Compatibilità
Salva()
Condividi
Recapiti
Vuoi vedere nel tuo digest i prossimi comunicati di questo professionista?

Comunicati correlati

02/02/2026
Industria
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
Scopri affinità
0
14/01/2025
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
Scopri affinità
0
12/12/2025
Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome
Fonte
ACADIA Pharmaceuticals Inc.
Emittente
Business Wire
Scopri affinità
0